About Us

The Consortium has been settled with careful attention to gather an outstanding critical mass involving industrial profiles and RTD expertises, in order to achieve successfully the technical and scientific objectives, while ensuring competitive advantages for future exploitation activities.
The project has a highly interdisciplinary nature and encompasses different fields such as nano and biotechnologies, surgical technologies, physics and materials science, vascular medicine, and clinical protocols and regulatory issues for the collection of animal samples.

Our competence. by Wordle

The consortium is formed by 9 partners from five different regions and countries. The consortium is a balanced combination between vascular clinical and animal testing expertise (EXP, UMCU), public research centres (CRIB, IBEC, ULIV, UVa,), and 4 SME (EXP, CV, TPNBT, DLC) with broad experience in the exploitation and dissemination of research results and technology transfer.